Pharmaceuticals distributor Prosper decides to merge with competitor

Prosper, a publicly-listed pharmaceuticals distributor, is considering a merger with one of its competitors. Plans for a potential merger have been on the cards for several years and currently Prosper is considering Farmacol and PGF as candidates and representatives of both parties have declared their openness to talks. "In my opinion, a further consolidation of the market must be continued. I'm rather surprised that Prosper decided to inform the media of the merger plans first. I have not yet received any concrete proposal. A merger is possible but everything depends on the terms under which it will be conducted. We have to calculate what we stand to gain or lose. I would also like to know how big a stake my company would offer in exchange for Prosper's shares," said Farmacol owner Wojciech Rosicki. According to Andrzej Stachnik, the president of Orfe, a company also interested in the merger, the second stage of the consolidation of the pharmaceuticals market is essential as the sector generates a small profit. "Such a merger could help in establishing a strong entity if the capacities of the merging companies allow," he added. (Puls Biznesu, p. 4) A.Z.